Comparison of two highly sensitive benzodiazepine immunoassay lab developed tests for urine drug testing in clinical specimens

BACKGROUND: The VALID Act is a legislative effort that, if enacted, would alter the regulatory requirements of laboratory developed tests (LDTs) used for clinical testing in the United States. Benzodiazepines, which are primarily excreted into urine as glucuronidated metabolites such as lorazepam, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lund, Kyle, Menlyadiev, Marlen, Lee, Kyunghoon, Kelner, Michael J., Fitzgerald, Robert L., Suhandynata, Raymond T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020650/
https://www.ncbi.nlm.nih.gov/pubmed/36937812
http://dx.doi.org/10.1016/j.jmsacl.2023.02.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020650/
https://www.ncbi.nlm.nih.gov/pubmed/36937812
http://dx.doi.org/10.1016/j.jmsacl.2023.02.010

Ejemplares similares